It's an accelerated approval which allows the company 9 years to conduct a confirmatory study, which isn't particularly strict around timing it seems. Another long term study for CGS, meanwhile Biogen stock up 42% after they priced it at the top end of expectations.
5 Weeks until Aducanumab PDUFA date, page-15
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.025(2.31%) |
Mkt cap ! $188.7M | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.11 | $1.07 | $63.06K | 58.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 3351 | 1 |
View Market Depth
| Last trade - 15.29pm 05/07/2024 (20 minute delay) ? |
| CGS (ASX) Chart |